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Preparation of Solutions:  
Protein: Thaumatin (Sigma) was dissolved in 0.1 M pH 6.5 buffer of N-(2-
acetamido)iminodiacetic acid (ADA buffer) to make a stock solution of high 
concentration. The stock solution was centrifuged at 13.2 krpm for 30 seconds 
(Eppendorf, centrifuge 5415D), and filtered with a 0.22 µm Millipore filter.  The precise 
concentration of the stock solution was determined by measuring the UV-Vis (Agilent, 
8453 UV-Visible system) of the solution after dilution of 30 times using an extinction 
coefficient of 28270 L·mol-1·cm-1 at 280 nm and a molecular weight of 22,000 Dalton. 
The stock solution was then diluted to the desired concentration with filtered ADA 
buffer.  All thaumatin solutions were freshly made several hours before the experiment. 
Buffer stream: 0.1 M pH 7.0 buffer of N-[2-hydroxyethyl]piperazine-N’-[2-
ethenesulfonic acid]) (HEPES buffer, Sigma) was used.  
Precipitant stream: 2.0 M sodium potassium tartrate (Sigma) in 0.1 M pH 7.0 
HEPES buffer was used.  
Carrier Fluid: the carrier fluid was a 10: 1 (v/v) mixture of FC 3283 (3M) : 
1H,1H,2H,2H-perfluoro-1-octanol (Acros Organics). 
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Experimental details for each figure: 
Figure 1: The microfluidic devices were fabricated using soft lithography 
(McDonald, J. C.; Whitesides, G. M. Accounts Chem. Res. 2002, 35, 491-499.) as 
described previously (Angew. Chem. Int. Ed. 2004, 43, 2508-2511). The devices used 
consisted of two parts (refer to Figure 1a for a schematic of the device): the first part was 
a polydimethylsiloxane (PDMS) microfluidic device with channels of 200 × 200 µm2 
cross-sectional dimensions; the second part was an X-ray capillary with ID 180 µm and 
OD 200 µm (Hampton Research). The capillary was cleaned with chromic acid before 
use.  The capillary was connected to the PDMS channel and the junction was sealed by 
partially cured PDMS.  The partially cured PDMS was allowed to fully cure immediately 
afterwards in a 60°C oven for 10 min.  The inner wall of the PDMS channels and the 
capillary was treated with N2 flow (100 mm Hg) containing the vapor of tri(decafluoro-
1,1,2,2-tetrahydrooctyl)-1-trichlorosilane (United Chemical Technologies, Inc.) for 30 
min, flushed with FC 3283 (3M) and baked in a 60°C oven for at least 2 hours.  Before 
each experiment, the aqueous inlets of the device was made hydrophilic by filling the 
inlets with 5% BSA solution in PBS buffer for 10 seconds and sucking the solution out 
with vacuum.  This procedure helped to maintain the flow stability. 
The mixing experiments were performed in an 18°C room.  Plugs of a mixture of 
protein, buffer and precipitant were formed and mixed in the microfluidic channel and 
transported to the glass capillary connected to the channel by injecting solutions of carrier 
fluid, thaumatin protein, buffer, and precipitant into the device.  We used Harvard 
Apparatus PHD 2000 Infusion pumps and Hamilton Gastight syringes to inject solutions.  
50-µL Hamilton Gastight syringes (1700 series, RN) with removable needles of 27-gauge 
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were used with 30-gauge Teflon tubing from Weico Wire & Cable to drive aqueous 
flows.  1-mL Hamilton Gastight syringes (1700 series, TLL) were used with 30-gauge 
Teflon needles with one hub from Hamilton for carrier fluid.  All the solutions were 
filtered with 0.22 µm Millipore filters right before the experiment. 
After the glass capillary was filled with plugs, the capillary was cut off from the 
PDMS device with the solutions still flowing.  The capillary was sealed at two ends with 
capillary wax (Hampton Research) and kept in an 18°C incubator for the protein to 
crystallize in plugs.  Every 3 hours the capillary was taken to the 18°C room to check for 
crystals that appeared in each plug. 
The flow rates of each solution used in Figure 1 are listed in the table below: 
 Carrier fluid 
(µL/min) 
Protein 
(µL/min) 
Buffer 
(µL/min) 
Precipitant 
(µL/min) 
Slow 3.6 0.40 0.04 0.40 
Fast 20.0 6.00 0.60 6.00 
 
Figure 3a: The error bar for each data point in Figure 3a indicates +/-- one 
standard deviation of ~ 300 plugs from 5~6 different experiments.   
The device used in Figure 3a was the same as the devices in Figure 1, except that 
a Teflon capillary was used in place of a glass capillary.  The Teflon capillary (Zeus, NY) 
had an OD of 254 µm and an ID of 200 µm.  The fabrication and surface treatment of the 
channels were also the same as in Figure 1. 
The mixing experiments were performed using almost the same procedures as in 
Figure 1.  Instead of transporting plugs to the glass capillary connected to the PDMS 
channel, plugs were transported to a piece of Teflon capillary via a glass coupler (Inner-
LokTM, Polymicro).  The surface of the glass coupler was made hydrophobic by cleaning 
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with chromic acid, treating with N2 flow (100 mm Hg) containing the vapor of 
tri(decafluoro-1,1,2,2-tetrahydrooctyl)-1-trichlorosilane (United Chemical Technologies, 
Inc.) for 30 min, flushing with FC 3283 (3M) and baking in a 60°C oven for at least 30 
min.  
The Teflon capillary containing crystallization plugs was inserted into a glass 
capillary and sealed at two ends with capillary wax to prevent evaporation.  The 
capillaries were kept in an 18°C incubator and the crystals in each plug were counted 
every 3 hours in an 18°C room.  The crystals grew rapidly at first and then gradually 
stopped growing after reaching a certain size (~ 100 to 200 µm).  We could not use the 
crystal size to determine conclusively whether nucleation happened during mixing or 
after mixing. 
The solutions used in Figure 3a were: protein: 22.0 mg/mL thaumatin in 0.1 M 
ADA buffer pH 6.5; buffer: 0.1 M HEPES pH 7.0; precipitant: 2.0 M sodium potassium 
tartrate in 0.1 M HEPES buffer pH 7.0.  The flow rates of solutions for each data point in 
Figure 3a are listed below: 
Total flow rate 
(µL/min) 
Carrier fluid 
(µL/min) 
Protein 
(µL/min) 
Buffer 
(µL/min) 
Precipitant 
(µL/min) 
67.30 40.0 13.0 1.3 13.0 
30.50 20.0 5.0 0.5 5.0 
14.0 10.0 1.9 0.19 1.9 
7.89 6.0 0.90 0.09 0.90 
4.48 3.6 0.42 0.042 0.42 
 
Figure 3b: The devices were fabricated using the same procedures as described in 
Figure 1.  The devices with winding channels were the same as those used in Figure 1.  
The devices with straight channels had the same dimensions and inlet designs with the 
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devices of winding channels, except that the winding channels were replaced with 
straight channels.   
 
Figure S 1   A schematic of the device with straight channel used in Figure 3b. 
The mixing experiments, crystallization and data collection were performed 
following the same procedures as Figure 1. 
The solutions used in Figure 3b were: protein: 40.5 mg/mL thaumatin in 0.1 M 
ADA buffer pH 6.5; buffer: 0.1 M HEPES pH 7.0; precipitant: 2.0 M sodium potassium 
tartrate in 0.1 M HEPES buffer pH 7.0.  The flow rates of solutions used in Figure 3b are 
listed below: 
 Carrier fluid 
(µL/min) 
Protein 
(µL/min) 
Buffer 
(µL/min) 
Precipitant 
(µL/min) 
Low flow rate 4.0 2.0 1.0 1.0 
High flow rate 30.0 15.0 7.5 7.5 
 
Visualizing the flow patterns using hemoglobin. 
Hemoglobin (Sigma) was dissolved in 0.1 M ADA buffer to ~50 mg/mL. The 
solution was centrifuged at 13.2 krpm for 30 seconds (Eppendorf, centrifuge 5415D), and 
filtered with a 0.22 µm Millipore filter before use. The buffer streams used were 0.1 M 
pH 7.0 HEPES. 
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Figure S 2   a) A schematic of the microfluidic device; b), c) microphotographs of the plugs traveling in the 
microfluidic channels at low flow rate (b) and high flow rate (c). The scale bar is 200 µm.  
Footnote 11 
1)  Definitions in equation J ∝ exp[-C/(lnS)2] 
J is the number of nuclei formed per unit volume and per unit time; C is a 
parameter that depends on temperature, surface tension of the nuclei and molar volume of 
the growth units. One can find more detailed discussion of this equation in Garcia-Ruiz, 
J. M. J. Struct. Biol. 2003, 142, 22-31 (ref. 10 in the manuscript)  
2)  Measuring the solubility of thaumatin in salt solutions 
The solubility of thaumatin was measured by both dissolution of thaumatin 
crystals and crystallization of thaumatin solution.  To measure the solubility by 
crystallization, 15mg/mL thaumatin solution, HEPES buffer and precipitant (all were 
prepared as in the “preparation of solution” section) were mixed in an Eppendorf tube 
and kept in the 18°C incubator for the protein to crystallize.  To measure the solubility by 
dissolution, thaumatin crystals were first obtained from crystallization experiments, 
washed a few times with the precipitant solution of the desired composition, transferred 
to an Eppendorf tube with the precipitant solution and kept in the 18°C incubator.  The 
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Eppendorf tubes were wrapped with Parafilm to prevent evaporation.  After incubation 
for several weeks, an aliquot of the supernatant solution was taken from the tube to 
determine the concentration of thaumatin in the solution by UV-Vis as described in the 
“preparation of solutions” section.  The aliquot of the supernatant solution was 
centrifuged at 13.2 krpm for 30 seconds and filtered with a 0.22µm Millipore filter before 
UV-Vis measurement.  When the concentrations of thaumatin in solutions from 
dissolution and crystallization were the same, we took the concentration as the solubility 
of thaumatin under the particular precipitant concentration. 
The measured solubility (mg/mL) of thaumatin at 18°C and different salt 
concentrations were listed below: 
 
Calculating supersaturation of thaumatin in Figure 1: 
In Figure 1, the solubility of thaumatin was ~1.4 mg/mL. The supersaturation is 
defined as S=c/s, where c is the actual concentration of thaumatin, and s is the solubility 
of thaumatin.  The supersaturation after complete mixing: 
s=(22.0mg/mL/2.1)/(1.4mg/mL)=7.5. At the interfaces where protein is not diluted, 
s=22.0(mg/mL)/(1.4mg/mL)=15.7.  
Derivation of the qualitative scaling argument of the mixing effect  
A detailed description of mixing inside plugs traveling through a winding channel 
can be found in a previous publication (Appl. Phys. Lett. 2003, 83, 4664-4666).  In plugs 
there are interfaces where the solutions interdiffuse (Figure 2).  The interfaces stretch and 
Salt concentrations (M) Experiment 
KNa tartrate HEPES ADA 
Solubility from 
dissolution 
(mg/mL) 
Solubility from 
crystallization 
(mg/mL) 
Fig 1, Fig 3a 0.95 0.052 0.050 1.42 1.32 
Fig 3b 0.50 0.050 0.050 5.84 4.96 
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fold as the plug traveling through a winding channel.  Each stretching and folding (one 
cycle of advection) doubles the interfacial area and decreases the diffusion distance by 
half.  For a channel with width w [m] and flow velocity U [m/s], the time tconv [s] required 
for the plug to undergo one cycle of advection is aw/U, where a  is a unitless 
experimental parameter that depends on the device geometry.  After n cycles of 
advection, the diffusive mixing time tdiff [s] (time required for the plug to be mixed by 
mere diffusion) becomes tdiff=(w2-(n+1))2/D.  D [m2/s] is the diffusion coefficient.  Full 
mixing will be achieved when the time tconv required for the plug to undergo another cycle 
of convection equals to diffusive mixing time tdiff, which is tconv=aw/U=(w2-(n+1))2/D= tdiff.  
According to this equation, at the time the solutions are completely mixed (tmix), 
2n+1=(wU/Da)1/2 (Equation 1).  
With the assumptions we made in the manuscript, the total number ( N ) of 
nucleation events from mixing should be proportional to the product of the total interface 
area A (determined by tmix) and the time tconv required for the plug to undergo 1 cycle of 
advection, so N ∝ A(tmix)tconv=A02naw/U (Equation 2).  Here n  is the number of advection 
cycles at tmix , and A0 is the interface area before the first cycle of advection.  Substituting 
Equation 1 into Equation 2 yields N ∝ (A0/2)(wU/Da)1/2aw/U=(A0/2)(a/DU)1/2w3/2.  
Considering that A0 ∝ w2and discarding the constants, we get N ∝ w7/2(DU)-1/2. 
Removing the second assumption (every newly generated interface is fresh for 
only one cycle of convection) in the main text leads to a qualitatively similar result.  
Removal of this assumption assumes that nucleation happens at the interface until mixing 
in the plug is complete.  The number ( N ) of nucleation events from mixing during a 
cycle of convection (corresponding to a time interval of tconv=aw/U) will be proportional 
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to the product of the interfacial area A(n) at the time and tconv.  The total number of 
nucleation ( N ) events from mixing is a sum of nucleation during all the convection 
cycles, N A n aw U dn
m
∝
∫
( ) * ( / )
0
 (Equation 3), where m is the number of cycles of 
advection needed before mixing is complete.  In Equation 3, A(n)=A02n.  Integrating 
Equation 3 gives N ∝ A0awem/(Uln2).  Combining this equation with Equation 1 gives 
N ∝ A0(aw/Uln2)[(1/2)(wU/Da)1/2]1/ln2 ∝ (A0w/U)(wU/D)1/(2ln2).  Taking into account 
A0 ∝ w2, N ∝ w3+1/(2ln2)/(U1-1/(2ln2)D1/(2ln2)).  This equation predicts a slightly weaker 
dependence of nucleation rate (N) on flow velocity (U). 
 
